Elthera Announces Positive Preclinical Proof of Concept (POC) Studies and Start of New Financing Round

March 18, 2018

Responsive image

SCHLIEREN, Switzerland, March 19, 2018 /PRNewswire/ — Elthera is pleased to announce that it has demonstrated efficacy of its proprietary antibodies in tumor bearing animals. Dr. Anne Schmidt, Elthera CEO said, “We are very encouraged by these results demonstrating the efficacy of our…

Category: Precious Metals